B cells in multiple sclerosis—from targeted depletion to immune reconstitution therapies

MT Cencioni, M Mattoscio, R Magliozzi… - Nature Reviews …, 2021 - nature.com
Increasing evidence indicates the involvement of B cells in the pathogenesis of multiple
sclerosis (MS), but their precise roles are unclear. In this Review, we provide an overview of …

The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment

AP Robinson, CT Harp, A Noronha, SD Miller - Handbook of clinical …, 2014 - Elsevier
While no single model can exactly recapitulate all aspects of multiple sclerosis (MS), animal
models are essential in understanding the induction and pathogenesis of the disease and to …

[HTML][HTML] The cerebrospinal fluid in multiple sclerosis

F Deisenhammer, H Zetterberg, B Fitzner… - Frontiers in …, 2019 - frontiersin.org
Investigation of cerebrospinal fluid (CSF) in the diagnostic work-up in suspected multiple
sclerosis (MS) patients has regained attention in the latest version of the diagnostic criteria …

Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients

AH Cross, JL Stark, J Lauber, MJ Ramsbottom… - Journal of …, 2006 - Elsevier
Effects of B cell depletion by rituximab, a monoclonal antibody to CD20, were studied in
patients with relapsing MS that had not responded optimally to standard immunomodulatory …

[HTML][HTML] Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS

LM Villar, MC Sádaba, E Roldán… - The Journal of …, 2005 - Am Soc Clin Investig
Oligoclonal IgM bands restricted to cerebrospinal fluid are an unfavorable prognostic marker
in MS, the most common demyelinating disease of the CNS. We have attempted to identify …

Intrathecal oligoclonal IgG synthesis in multiple sclerosis

A Petzold - Journal of neuroimmunology, 2013 - Elsevier
The diagnosis of multiple sclerosis is based on dissemination in time and space. Before
2010 lack of evidence for dissemination in space could be substituted by a paraclinical test …

Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis

LM Villar, J Masjuan… - Annals of Neurology …, 2003 - Wiley Online Library
Intrathecal IgM synthesis (ITMS) predicts a worse evolution in the first stages of multiple
sclerosis (MS). The aim of this study was the follow‐up of a group of relapsing‐remitting MS …

Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid

GP Owens, AM Ritchie, MP Burgoon… - The Journal of …, 2003 - journals.aai.org
Single-cell RT-PCR was used to sample CD19+ B cell repertoires in cerebrospinal fluid
(CSF) of patients with multiple sclerosis (MS) or viral meningitis. Analysis of amplified Ab H …

Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS

LM Villar, J Masjuan, P Gonzalez-Porque, J Plaza… - Neurology, 2002 - AAN Enterprises
Background: The authors have recently described that intrathecal IgM synthesis (ITMS)
correlates with a higher disability in patients with clinically definite MS (CDMS). Objective: To …

Targeting B cells in relapsing–remitting multiple sclerosis: from pathophysiology to optimal clinical management

S Bittner, T Ruck, H Wiendl… - Therapeutic …, 2017 - journals.sagepub.com
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease that is caused by an
autoimmune response against central nervous system (CNS) structures. Traditionally …